Congress didn't hand the nuclear industry a subsidy in the ADVANCE Act — it handed it a discount and a stopwatch, and those two things are worth more than cash. The 2024 law cuts NRC hourly licensing fees for advanced reactor applicants and forces the agency onto statutory review deadlines. That matters because for decades the single biggest cost of building a new reactor in America wasn't concrete or steel — it was the NRC's hourly-billed review process, which could run tens of millions of dollars and years longer than promised before a shovel ever hit dirt. Cheaper, faster, more predictable licensing changes the economics of every reactor developer's balance sheet — but not equally. Design maturity decides who benefits most, and that's where Oklo and NuScale split.
The NRC Discount Helps Oklo More Than NuScale — Because NuScale Already Paid Full Price
The ADVANCE Act's NRC fee cuts and faster clocks are a bigger gift to earlier-stage designs than to ones that already cleared the hardest gate — which flips the usual Oklo-vs-NuScale script.
Fee cuts and faster clocks help the applicants still in line — not the one that already reached the front of it.
Who cashes in:
OKLO is the biggest beneficiary of the fee relief and timeline reform specifically because it still has the most licensing runway ahead of it. Oklo's Aurora is a sodium-cooled fast reactor micro-design pursuing a combined license application under 10 CFR Part 50, and every fee-per-hour reduction and every deadline the NRC is now statutorily bound to hit shows up directly as lower burn and a shorter runway-to-revenue in Oklo's model. The company has no revenue yet — regulatory cost and speed are existential inputs, not a rounding error.
CEG (Constellation) and VST (Vistra) cash in on the second-order effect: cheaper, faster advanced-reactor licensing improves the economics of restarting and uprating existing nuclear fleets and pairing new SMR/microreactor capacity with data-center and grid demand, where both companies already have merchant nuclear scale and hyperscaler power-purchase relationships.
BWXT benefits as the fuel-fabrication and component-manufacturing backbone for advanced reactors (including HALEU-class fuel work), gaining volume as more designs clear licensing gates faster.
Who is exposed:
SMR (NuScale) is the counterintuitive loser of the comparison, not because the ADVANCE Act hurts it, but because it benefits far less at the margin. NuScale's VOYGR design already holds NRC design certification — the expensive, slow, first-of-a-kind review is behind it. Fee cuts and faster clocks help future applicants far more than a design that already cleared the hardest gate; NuScale's remaining bottleneck is customer contracting and project financing, not NRC throughput.
LEU (Centrus) carries HALEU supply-chain execution risk that licensing reform doesn't touch — faster reactor approvals increase enriched-fuel demand pressure before supply scales.
The play: This isn't "nuclear is back," it's "which nuclear balance sheet gets the regulatory discount." Watch NRC docket dates and Part 53 rulemaking progress — the earlier-stage the design, the bigger the ADVANCE Act windfall.
Source: original report ↗
Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/moJoin the owners who run ahead of the industry. Cancel anytime, one click.